Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification by the CEO Pursuant to Securities Exchange Act of 1934
- 31.2 Certification by the CFO Pursuant to Securities Exchange Act of 1934
- 32.1 Certification by the CEO Pursuant to Sarbanes-oxley Act of 2002
- 32.2 Certification by the CFO Pursuant to Sarbanes-oxley Act of 2002
CHTP similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements on Forms S-3 (Nos. 333-132330, 333-123916 and 333-146422) and Forms S-8 (Nos. 333-137782 and 333-144061) of our reports dated March 10, 2008 relating to the consolidated financial statements of Chelsea Therapeutics International, Ltd. and Subsidiary and the effectiveness of internal control over financial reporting of Chelsea Therapeutics International, Ltd. and Subsidiary as of December 31, 2007 included in this Annual Report on Form 10-K of Chelsea Therapeutics International, Ltd. for the year ended December 31, 2007.
/s/ J. H. COHN LLP
Roseland, New Jersey
March 10, 2008